Results 151 to 160 of about 4,602 (184)

Bisphosphonate‐associated osteonecrosis of the jaws: The limits of a conservative approach

Head & Neck, 2009
AbstractBackground.An increasing number of cases of osteonecrosis of the jaws (ONJ) in patients treated with bisphosphonates has been reported in the literature. ONJ significantly affects the patients' quality of life and its management is still extremely difficult.Methods.A woman with ONJ secondary to therapy with zoledronic acid came to our attention
TIRELLI, GIAN CARLO, BIASOTTO, MATTEO, CHIANDUSSI S, DORE F, DE NARDI E, DI LENARDA, Roberto   +5 more
openaire   +3 more sources

Clinical aspects and management of bisphosphonates-associated osteonecrosis of the jaws

Acta Odontologica Scandinavica, 2006
An increasing incidence of osteonecrosis of the jaws (ONJ) in patients treated with intravenous bisphosphonates has been reported in the literature. The aim of this study was to evaluate the clinical aspects, diagnostic investigations, and management of ONJ associated with bisphosphonates in a series of 12 patients.Our patients included 1 asymptomatic ...
BIASOTTO, MATTEO, CHIANDUSSI S, DORE F, RINALDI A, RIZZARDI, CLARA, CAVALLI F, DI LENARDA, Roberto   +6 more
openaire   +3 more sources

Bisphosphonate‐associated osteonecrosis of the jaw: does it occur in children?

Clinical Endocrinology, 2008
SummaryBackground  Bisphosphonate use in adult patients has been linked to osteonecrosis of the jaw (ONJ). This complication has not been systematically assessed in a paediatric population receiving bisphosphonates.Objective  To assess our cohort of paediatric patients treated with intravenous bisphosphonate for occurrence of ONJ.Design  Observational ...
J J, Brown, L, Ramalingam, M R, Zacharin
openaire   +2 more sources

Nature and Frequency of Bisphosphonate-Associated Osteonecrosis of the Jaws in Australia

Journal of Oral and Maxillofacial Surgery, 2007
The purpose of this study is to estimate the frequency and describe the clinical characteristics of patients diagnosed with bisphosphonate-associated osteonecrosis of the jaws (ONJ) in Australia.Cases of ONJ were identified in 2004 and 2005 primarily by a postal survey of Australian Oral and Maxillofacial Surgeons (OMS) with additional cases from other
Mavrokokki, T., Cheng, A., Stein, B., Goss, A.   +3 more
openaire   +3 more sources

[Bisphosphonate-associated osteonecrosis of the jaw].

Schmerz (Berlin, Germany), 2016
Bisphosphonates (BP) are used in the treatment of severe osteoporosis and metastasis of malignant diseases. A possible relationship between the occurrence of osteonecrosis of the jaw and BP therapy was first described in 2003. Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is difficult to treat.
S, Koy, M, Schubert, J, Koy, M, Ney, G, Lauer, R, Sabatowski   +5 more
openaire   +1 more source

Bisphosphonate-associated osteonecrosis can hide jaw metastases

Bone, 2007
Osteonecrosis of the jaw is a well known potential complication of bisphosphonate treatment but its pathogenesis is poorly understood. The current management of patients with bisphosphonate-associated osteonecrosis (BON) is based on "expert recommendations" and there is a recognized need of better evidence.
BEDOGNI, ALBERTO, SAIA, GIORGIA, RAGAZZO M, BETTINI G, CAPELLI P, D'ALESSANDRO E, NOCINI PF, LO RUSSO L, LO MUZIO L, BLANDAMURA, STELLA   +9 more
openaire   +3 more sources

Bisphosphonate-associated osteonecrosis of the jaws

Journal of Oral and Maxillofacial Surgery, 2005
MICHAEL R. MARKIEWICZ, JOSEPH E. MARGARONE, JOHN H. CAMPBELL, ALFREDO AGUIRRE   +3 more
openaire   +3 more sources

[Bisphosphonate-associated osteonecrosis of the jaws 1].

Nederlands tijdschrift voor tandheelkunde, 2007
Bisphosphonates are generally administered either orally or intravenously. Orally administered bisphosphonates are primarilly used in the treatment of postmenopausal osteoporosis, glucocorticoid-induced osteoporosis, and Paget's disease. When orally administered, only about 1% is absorbed from the tractus from the tractus digestivus.
R H B, Allard, P, Lips, E M W, Eekhoff, J P R, van Merkesteyn, I, van der Waal   +4 more
openaire   +1 more source

Impact of dental care in the prevention of bisphosphonate-associated osteonecrosis of the jaw: a single-center clinical experience

Annals of Oncology, 2012
A M Vandone, M Donadio, Ludovica Ciuffreda   +2 more
exaly  

Can children be affected by bisphosphonate-related osteonecrosis of the jaw? A systematic review

International Journal of Oral and Maxillofacial Surgery, 2020
Nathalia Tuany Duarte, Bruna De Oliveira Rech, Juliana Bertoldi Franco   +2 more
exaly